539730
FREDUN
Start SIP
Invest Now
Start SIP in FREDUN
Performance
- Low
- ₹1,510
- High
- ₹1,627
- 52 Week Low
- ₹635
- 52 Week High
- ₹1,999
- Open Price₹1,550
- Previous Close₹1,536
- Volume13,315
Investment Returns
- Over 1 Month -18.18%
- Over 3 Month + 19.24%
- Over 6 Month + 96.28%
- Over 1 Year + 111.9%
Smart Investing Starts Here Start SIP with Fredun Pharmaceuticals for Steady Growth!
Fredun Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 25.9
- PEG Ratio
- 0.4
- Market Cap Cr
- 748
- P/B Ratio
- 4.7
- Average True Range
- 102.35
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -25.74
- RSI
- 41.93
- MFI
- 43.54
Fredun Pharmaceuticals Financials
Fredun Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,584.90
+
48.65
(3.17%)
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹1,670.71
- 50 Day
- ₹1,655.36
- 100 Day
- ₹1,505.78
- 200 Day
- ₹1,277.76
Resistance and Support
1573.97
- R3 1,754.93
- R2 1,690.97
- R1 1,637.93
- S1 1,520.93
- S2 1,456.97
- S3 1,403.93
Fredun Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-08 | Quarterly Results | |
| 2025-09-25 | Preferential Issue of shares & Others | To consider 1. Issue Of Warrants. alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method. |
| 2025-07-30 | Quarterly Results | |
| 2025-05-30 | Audited Results & Dividend | |
| 2025-02-04 | Quarterly Results |
Fredun Pharmaceuticals F&O
About Fredun Pharmaceuticals
- NSE Symbol
- FREDUN
- BSE Symbol
- 539730
- Managing Director & CFO
- Mr. Fredun Medhora
- ISIN
- INE194R01017
Similar Stocks to Fredun Pharmaceuticals
Fredun Pharmaceuticals FAQs
Fredun Pharmaceuticals share price is ₹1,584 As on 03 January, 2026 | 10:43
The Market Cap of Fredun Pharmaceuticals is ₹748.3 Cr As on 03 January, 2026 | 10:43
The P/E ratio of Fredun Pharmaceuticals is 25.9 As on 03 January, 2026 | 10:43
The PB ratio of Fredun Pharmaceuticals is 4.7 As on 03 January, 2026 | 10:43
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.